Allscripts Healthcare Solutions (NasdaqGS:MDRX) - Share price, News & Analysis

MDRX fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	1/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

MDRX Stock Overview

Rewards

Trading at 52.3% below our estimate of its fair value

Earnings are forecast to grow 8.05% per year

Became profitable this year

Risk Analysis

Large one-off items impacting financial results

Significant insider selling over the past 3 months

Allscripts Healthcare Solutions Competitors

Cerner

NasdaqGS:CERN

US$27.8b

Change Healthcare

NasdaqGS:CHNG

US$7.2b

Doximity

NYSE:DOCS

US$6.6b

Teladoc Health

NYSE:TDOC

US$5.1b

Price History & Performance

Summary of all time highs, changes and price drops for Allscripts Healthcare Solutions
Historical stock prices
Current Share Price	US$17.30
52 Week High	US$23.25
52 Week Low	US$13.05
Beta	0.98
1 Month Change	-20.90%
3 Month Change	-14.95%
1 Year Change	-1.03%
3 Year Change	70.11%
5 Year Change	51.62%
Change since IPO	218.02%

Recent News & Updates

May 03

We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Shareholder Returns

	MDRX	US Healthcare Services	US Market
7D	2.1%	4.0%	1.0%
1Y	-1.0%	-40.3%	-15.1%

Return vs Industry: MDRX exceeded the US Healthcare Services industry which returned -40.1% over the past year.

Return vs Market: MDRX exceeded the US Market which returned -13.2% over the past year.

Price Volatility

Is MDRX's price volatile compared to industry and market?
MDRX volatility
MDRX Average Weekly Movement	5.2%
Healthcare Services Industry Average Movement	12.5%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	2.9%

Stable Share Price: MDRX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: MDRX's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1986	8,000	Rick Poulton	https://www.allscripts.com

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm.

Allscripts Healthcare Solutions Fundamentals Summary

How do Allscripts Healthcare Solutions's earnings and revenue compare to its market cap?
MDRX fundamental statistics
Market Cap	US$2.01b
Earnings (TTM)	US$148.15m
Revenue (TTM)	US$1.51b

13.5x

P/E Ratio

1.3x

P/S Ratio

Is MDRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
MDRX income statement (TTM)
Revenue	US$1.51b
Cost of Revenue	US$763.23m
Gross Profit	US$748.83m
Other Expenses	US$600.68m
Earnings	US$148.15m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	1.28
Gross Margin	49.52%
Net Profit Margin	9.80%
Debt/Equity Ratio	27.9%

How did MDRX perform over the long term?

See historical performance and comparison

Valuation

Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: MDRX ($17.3) is trading below our estimate of fair value ($36.25)

Significantly Below Fair Value: MDRX is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: MDRX is good value based on its Price-To-Earnings Ratio (13.5x) compared to the US Healthcare Services industry average (46.5x).

PE vs Market: MDRX is good value based on its Price-To-Earnings Ratio (13.5x) compared to the US market (14.9x).

Price to Earnings Growth Ratio

PEG Ratio: MDRX is poor value based on its PEG Ratio (1.7x)

Price to Book Ratio

PB vs Industry: MDRX is good value based on its Price-To-Book Ratio (1.5x) compared to the US Healthcare Services industry average (2x).

Future Growth

How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

8.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDRX's forecast earnings growth (8% per year) is above the savings rate (1.9%).

Earnings vs Market: MDRX's earnings (8% per year) are forecast to grow slower than the US market (12.1% per year).

High Growth Earnings: MDRX's earnings are forecast to grow, but not significantly.

Revenue vs Market: MDRX's revenue is expected to decline over the next 3 years (-2.2% per year).

High Growth Revenue: MDRX's revenue is forecast to decline over the next 3 years (-2.2% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MDRX's Return on Equity is forecast to be high in 3 years time

Past Performance

How has Allscripts Healthcare Solutions performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

20.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MDRX has a large one-off gain of $59.1M impacting its March 31 2022 financial results.

Growing Profit Margin: MDRX became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: MDRX has become profitable over the past 5 years, growing earnings by 20.2% per year.

Accelerating Growth: MDRX has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: MDRX has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.5%).

Return on Equity

High ROE: MDRX's Return on Equity (10.9%) is considered low.

Financial Health

How is Allscripts Healthcare Solutions's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: MDRX's short term assets ($1.5B) exceed its short term liabilities ($646.9M).

Long Term Liabilities: MDRX's short term assets ($1.5B) exceed its long term liabilities ($430.3M).

Debt to Equity History and Analysis

Debt Level: MDRX's net debt to equity ratio (21.7%) is considered satisfactory.

Reducing Debt: MDRX's debt to equity ratio has reduced from 82.5% to 27.9% over the past 5 years.

Debt Coverage: MDRX's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: MDRX's interest payments on its debt are well covered by EBIT (20.1x coverage).

Balance Sheet

Dividend

What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MDRX has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.2yrs

Average management tenure

CEO

Rick Poulton (56 yo)

no data

Tenure

US$7,613,839

Compensation

Mr. Richard J. Poulton, also known as Rick, serves as Chief Executive Officer at Allscripts Healthcare Solutions, Inc. since May 06, 2022. Mr. Poulton served as the President of Allscripts Healthcare Solut...

CEO Compensation Analysis

Compensation vs Market: Rick's total compensation ($USD7.61M) is above average for companies of similar size in the US market ($USD5.44M).

Compensation vs Earnings: Rick's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: MDRX's management team is considered experienced (2.2 years average tenure).

Board Members

Experienced Board: MDRX's board of directors are considered experienced (6 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: MDRX insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/25 00:00
End of Day Share Price	2022/05/25 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31